Biofrontera Inc.
Biofrontera Inc. (BFRI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BFRI · as of Jun 8, 2026
Key Statistics
Explore Biofrontera Inc. Data
bfri stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
bfri competitorsBFRI
AYTU
COCP
DWTX
EVGN
GELSStock Performance
Full HistoryAbout Biofrontera Inc.
Biofrontera Inc. is a biopharmaceutical enterprise dedicated to the marketing and distribution of pharmaceutical products within the United States, specifically targeting various dermatological condit…
what is biofrontera inc. · bfri stock overview · biofrontera inc. company profile · who is biofrontera inc. ceo · bfri NASDAQ · biofrontera inc. headquarters · biofrontera inc. business segments
About Stock Overview & Key Data
Biofrontera Inc. (BFRI) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Oct 29, 2021. As of the latest trading session, BFRI stock price is $0.93, with a market capitalization of $11.9M. The stock has returned +56.92% over the past 12 months and +65.18% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Biofrontera Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Biofrontera Inc. reported revenue of $41.7M and net income of -$10.5M. For detailed data — including Biofrontera Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Biofrontera Inc. (BFRI) stock price is $0.93. The stock is traded on NASDAQ under the ticker symbol BFRI. The 52-week range is $0.56 – $1.19.